European Court Sides With Glaxo In Dual Pricing Case
Drug giant GlaxoSmithKline won a big victory Wednesday when the European Court of First Instance decided that a European Commission was wrong when it said the company's subsidiary company couldn't charge...To view the full article, register now.
Already a subscriber? Click here to view full article